Medical technology company Andromed Inc. cut its third-quarter loss as the firm eyes its possible sale. Andromed said it lost $940,096 (6 cents a share), compared with a loss of $1.3 million (7 cents ...
Please enable JavaScript to view this content.
This article was published more than 21 years ago. Some information may no longer be current.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results